The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients

NACompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1998

Conditions
Mycobacterium Avium-intracellulare InfectionHIV Infections
Interventions
DRUG

Clarithromycin

DRUG

Azithromycin

DRUG

Rifabutin

Trial Locations (11)

20007

Georgetown Univ Med Ctr, Washington D.C.

21201

Univ of Maryland at Baltimore / Veterans Adm, Baltimore

63108

Washington Univ School of Medicine, St Louis

85724

Univ of Arizona / Health Science Ctr, Tucson

94114

Davies Med Ctr, San Francisco

94304

Palo Alto Veterans Affairs Health Care System, Palo Alto

232980533

Med College of Virginia / School of Pharmacy, Richmond

275997215

Univ of North Carolina School of Medicine, Chapel Hill

701122699

Tulane Univ Med School, New Orleans

802044507

Denver Public Health Dept, Denver

02908

Univ of Rhode Island / Roger Williams Med Ctr, Providence

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH